CUV vs EYE

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

CUV

CLINUVEL FPO [CUV]

62MEDIUM-HIGH

EYE

NOVA EYE FPO [EYE]

58MEDIUM

Score Breakdown

CUV EYE
Technical
39
46
Catalyst
54
54
Sentiment
50
50
Fundamental
91
60
Momentum
47
65
Risk Gate
40
50

Key Metrics

CUV Metric EYE
$419.1MMarket Cap$38.5M
167KAvg Volume (20d)199K
+8.1%Short InterestN/A
$13.48052-Week High$0.205
$8.01052-Week Low$0.100
-1.2%Daily Change+3.8%
$8.260Reference Price$0.135
+13.2%ROE-26.1%
+36.1%Profit Margin-12.4%

Active Signals

CUV Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Volume surging at 3.1x normal while price falls — heavy selling pressure
●Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (4.5x)

EYE Signals

●Stochastic just turned bullish from a low level — early reversal sign
●Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.2 quarters)
●Low P/S ratio (1.1x)
●Moderate revenue growth (+11%)
●EPS estimates revised upward (+10pts)
●Small-cap ($20-100M)

Ask Scout AI to compare CUV and EYE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EYE vs MVP →CGS vs CUV →CGS vs MVP →EYE vs IMM →AHC vs EYE →
CUV Full Analysis → EYE Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).